Drugs / Ringerfundin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT02461329 | May 2015 → Sep 2016 | bleeding disorder, vascular-type, blood platelet disease | Kratochvil Milan, MD | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02691676 Comparator | Jan → Dec 2014 | disorder of acid-base balance | University Hospital Olomouc | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ringerfundin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02691676 ↗ |
| Known as | Ringerfundin (B. Braun) | “Ringerfundin (B. Braun)” NCT02691676 ↗ |
| Route | Intravenous | “infusion via intravenous boluses” NCT02461329 ↗ |